KoreMed Consulting Group

"Did you know?

The world's first antibody biosimilar was approved in Korea — not the US, not Europe. Celltrion's Remsima (infliximab) cleared Korea's MFDS in July 2012, more than a year before Europe's EMA followed in September 2013. It's now used worldwide to treat rheumatoid arthritis, Crohn's disease, and other autoimmune conditions.

Source: Korea MFDS (2012); EMA Remsima EPAR (2013). Informational only, not medical advice. Approval status varies by country.

visit our website: koremedconsulting.com

SAVE THIS POST — Americans: Here's exactly how to get medical care in Korea 🇰🇷

Most people think Korean healthcare is complicated to access.
It's not. You just need to know the steps.

Here's the complete roadmap 👇

STEP 1 — Visa
US citizens: No visa needed for up to 90 days. You're already cleared.(Medical Tourism Visa C-3-3 available for longer stays)

STEP 2 — Find Your Hospital
These are the top 5 hospitals US patients use:
• Asan Medical Center (cancer, complex surgery)
• Samsung Medical Center (robotic surgery, health screening)
• Seoul National University Hospital (flagship academic center)
• Severance Hospital / Yonsei (international patient program)
• Seoul St. Mary's Hospital (oncology, bone marrow)
• Gangnam JS Hospital (Knee cartilage regenerative stem cell surgery)

All have dedicated English-speaking international patient centers.

STEP 3 — Submit Your Records
Email your medical records directly to the hospital's International Health Care Center. They review and respond in 3–10 business days with a cost estimate.

STEP 4 — Book & Pay Deposit
Wire transfer, Visa/Mastercard, or Amex. Deposit is typically 20–50%.

STEP 5 — Arrive & Get Treated
Land at Incheon Airport → 60–90 min to central Seoul hospitals.
Most surgical procedures scheduled 3–5 days after arrival.
(A lot of times, hospitals offer pick up service)

STEP 6 — Return Home With Records
Get your full English discharge summary, imaging, and operative report before you fly. Book your US follow-up before leaving Korea.

Question: Have you ever considered getting medical care outside the US? Drop a in the comments — we read every one.

📖 Full step-by-step guide (visas, payments, insurance, follow-up care):
🔗 https://koremedconsulting.com/blog/korea-healthcare-accessibility-americans/

Know someone weighing their healthcare options? Tag them below or share this post. More people deserve to know this exists.

Follow for more guides on Korean medical travel

How Americans Actually Access Korean Healthcare: A Practical Step-by-Step Guide Practical logistics for US patients: Korean medical visa, international patient centers, booking procedures, payments, and what to expect before, during, and after treatment.

Korea's 5-year stomach cancer survival rate is 69%.
Most countries don't even reach 30%.
This isn't a rumor.

It's from CONCORD-3 — the largest global cancer survival study ever published, in The Lancet, covering 37.5 million patients across 71 countries.

For colorectal cancer, Korea's numbers are just as striking:
🔹 Colon cancer: 72% survival
🔹 Re**al cancer: 71% survival

Why is Korea so far ahead?

✅ National screening programs that catch stomach cancer early (73% of cases by 2016 — up from just 39% in 2001)
✅ Surgeons performing thousands of procedures, not hundreds
✅ Stomach cancer mortality dropped to 1/5 of its 1999 rate by 2021

If you or someone you love is facing a cancer diagnosis, this data is medically relevant — and most patients never see it.

We broke it all down in our latest article 👇
🔗 Read the full blog https://bit.ly/4p9sYxs

KoreMed Consulting connects US patients with Korea's leading cancer hospitals. Questions? DM us or visit our site.

Statistics sourced from CONCORD-3, The Lancet 2018. Individual outcomes vary. This is not medical advice.

한국의 위암 5년 생존율은 **69%**입니다.
대부분의 나라는 30%도 채 되지 않습니다.
이건 추측이 아닙니다.

The Lancet에 발표된 CONCORD-3 — 역대 최대 규모의 글로벌 암 생존율 연구, 71개국 3,750만 명의 환자 데이터를 분석한 결과입니다.

대장암도 마찬가지입니다:

🔹 결장암: 72% 생존율
🔹 직장암: 71% 생존율

왜 한국이 이렇게 앞서 있을까요?

✅ 국가 암 검진 프로그램 — 2001년 39%에 불과하던 조기 발견율이 2016년엔 **73%**로 상승
✅ 수천 건의 수술 경험을 보유한 전문 외과팀
✅ 위암 사망률, 1999년 대비 5분의 1 수준으로 감소 (2021년 기준)

암 진단을 받으셨거나, 가족 중에 그런 분이 계신다면 — 이 데이터는 의료적으로 중요한 정보입니다. 그런데 대부분의 환자들은 이 사실을 모릅니다.
자세한 내용은 아래 링크에서 확인하세요 👇
🔗 블로그 전문 읽기 https://bit.ly/4p9sYxs

Your Oncologist Hasn't Told You This: Korea's Cancer Survival Rates Are Quietly Beating America's Korea's 5-year stomach cancer survival rate is 69% — among the world's highest. CONCORD-3 data shows Korea leading the US in multiple cancer outcomes.

173,000 Americans flew to Korea last year.
For medical treatment.
Not a trend. A shift.

In 2025, South Korea treated 2 million international patients for the first time in history.
And US patient numbers jumped 70.4% in a single year.
Here's why Americans are choosing Korea:

Medical costs 30–70% less than the US

5-year cancer survival rate: 73.7% — world-class outcomes

No 3-month waitlists. No insurance battles. Same-day care.

The #1 treatment Americans came for?
Dermatology — 44.3% of all US patient visits.
When your own healthcare system has $10,000 deductibles and a 6-month specialist waitlist —
flying to Seoul starts looking like the rational choice.
201 countries. 2 million patients. One destination.

Have you ever received medical treatment abroad, or considered it?
Drop your experience in the comments — I'd love to hear.



Full story: https://koremedconsulting.com/blog/korea-2-million-patients-2025/

미국인 17만 명이 올해 한국으로 날아갔다.
단순한 트렌드가 아니다. 이건 구조적인 변화다.
2025년, 한국은 역사상 처음으로 해외 환자 200만 명을 돌파했다.

그 중 미국 환자 수는 전년 대비 70.4% 급증했다.

미국 환자들이 한국을 선택하는 이유:

미국 대비 30~70% 저렴한 의료비

5년 암 생존율 73.7% — 세계 최상위 수준

대기 없이, 보험 분쟁 없이, 당일 치료

미국 환자가 가장 많이 찾은 진료과 1위?
피부과 — 전체 미국 환자의 44.3%.

공제금 1,000만 원, 전문의 예약은 6개월 뒤인 미국 의료 시스템 안에서 서울행 비행기가 오히려 합리적인 선택이 되고 있다.
201개국. 200만 환자. 하나의 목적지.
해외에서 의료 서비스를 받아보신 적 있나요? 혹은 고려해본 적 있으신가요?

경험이나 생각을 댓글로 나눠주세요

#한국의료관광 #의료관광 #한국병원 #한국의료 #해외의료

https://koremedconsulting.com/blog/korea-2-million-patients-2025/

2 Million Patients Can't Be Wrong: Why Korea Became the World's #1 Medical Tourism Destination In 2025, Korea treated 2 million international patients for the first time. US patient volume surged 70.4%. Here is what the data tells us about why.

Let me debunk the 6 biggest myths about getting medical care in Korea.

❌ MYTH: "Korean hospitals are low quality"
✅ FACT: Korea ranks #1 OECD for colorectal cancer survival. JCI hospitals meet global standards.

❌ MYTH: "You can't communicate in English"
✅ FACT: Top international hospitals have dedicated English coordinators and translators.

❌ MYTH: "If something goes wrong you're on your own"
✅ FACT: Korea has an official Medical Dispute Mediation Agency specifically for international patients.

❌ MYTH: "You need a medical visa"
✅ FACT: Americans enter Korea visa-free for 90 days. Most procedures fit within that window.

❌ MYTH: "It's only good for cosmetic surgery"
✅ FACT: Korea excels in oncology, orthopedics, cardiology, dental, dermatology, and fertility.

❌ MYTH: "The savings aren't worth the travel cost"
✅ FACT: Even after flights + hotel, most patients save $2,000–$20,000 on their procedure.

Which myth surprised you most? Comment below 👇

Korean scientists just changed the future of cancer treatment.

Researchers at KAIST (Korea Advanced Institute of Science and Technology) developed a revolutionary cancer therapy that works INSIDE the tumor itself — no lab extraction, no lengthy preparation.
Current CAR-based cancer immunotherapies require doctors to extract a patient's immune cells, modify them in a lab, and reinfuse them. It's costly, slow, and difficult to scale globally.

The KAIST team's breakthrough: when injected into the tumor, macrophages (immune cells already living inside the tumor) absorb the treatment and transform themselves into targeted cancer killers — right there, inside the body.

This is the kind of cutting-edge research happening in Korea's world-class universities right now. Korea isn't just a destination for aesthetic procedures. It's at the forefront of cancer treatment innovation.
Learn how Koremed connects patients with Korea's leading specialists.

Link in bio.
Koremedconsulting.com

KAIST 연구팀이 암 치료의 미래를 바꿨습니다.
카이스트(KAIST) 연구팀이 종양 내부에서 직접 작동하는 혁신적인 CAR-대식세포 치료법을 개발했습니다.
기존 CAR 기반 면역치료는 환자의 면역세포를 채취 → 실험실 유전자 편집 → 재주입하는 복잡한 과정이 필요했습니다. 비용이 높고 시간이 오래 걸리며 대규모 적용이 어렵습니다.
KAIST 팀의 혁신: 종양에 약물을 직접 주입하면, 이미 종양 내에 존재하는 대식세포가 약물을 흡수하고 스스로 암 표적 면역세포(CAR-대식세포)로 전환됩니다. 체외 처리 없이, 체내에서 즉시 작동합니다.
이것이 지금 한국 최고 대학에서 이루어지고 있는 연구의 수준입니다. 한국 최고의 전문의와 연결하는 방법, Koremed에 문의하세요.

#암치료 #카이스트